New wrinkle treatment eveotox takes on botox in major trial
NCT ID NCT06937944
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This phase 3 study tests a new injection called Eveotox, made from a lab-grown version of botulinum toxin, against Botox and a placebo for moderate to severe frown lines. About 669 adults aged 18 to 65 will receive one or more treatments. Researchers will check how well it smooths wrinkles and monitor for side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
recombinant botulinum toxin type A (Eveotox)
What this could lead to
If it works, this could offer a new, effective option for temporarily reducing frown lines between the eyebrows.
What could go wrong
This is a cosmetic treatment, not a cure. Results are temporary, and side effects like bruising or drooping eyelids are possible. It may not work as well as Botox.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE GLABELLAR LINES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University
RECRUITINGHangzhou, Zhejiang, China
-
Huashan Hospital, Fudan University
RECRUITINGShanghai, Shanghai Municipality, China
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, China
-
Peking University First Hospital
RECRUITINGBeijing, Beijing Municipality, China
-
Peking University Third Hospital
RECRUITINGBeijing, Beijing Municipality, China
-
The Affiliated Hospital of Xuzhou Medical University
RECRUITINGXuzhou, Jiangsu, China
-
The First Affiliated Hospital of Chongqing Medical University
RECRUITINGChongqing, Chongqing Municipality, China
-
The First Affiliated Hospital of Jinan University
RECRUITINGGuangzhou, Guangdong, China
-
The First Hospital of Hebei Medical University
RECRUITINGShijiazhuang, Hebei, China
-
The Third Affiliated Hospital of Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, China
-
The Third Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, China
-
Tianjin Medical University General Hospital
RECRUITINGTianjin, Tianjin Municipality, China
-
West China Hospital, Sichuan University
RECRUITINGChengdu, Sichuan, China
-
Xianyang Hospital of Yan'an University
RECRUITINGXianyang, Shanxi, China
-
Zhejiang Provincial People's Hospital
RECRUITINGHangzhou, Zhejiang, China